Using ApoE Genotyping to Promote Healthy Lifestyles in Finland - Psychological Impacts: Randomized Controlled Trial.
Common health recommendations often incite very little public response, as people instead require individualized information. The purpose of this study was to assess the psychological effects of personal genetic information, provided by different apoE genotypes, as a tool to promote lifestyle changes. This study was a one-year intervention study using healthy adults, aged 20-67 years (n = 107). Their experiences of state anxiety, threat and stage of change were measured three times over a 12 months period. These psychological experiences were assessed, during the genetic information gathering, for three groups: a high-risk group (Ɛ4+, n = 16); a low-risk group (Ɛ4-, n = 35); and a control group (n = 56). The psychological effects of personal genetic risk information were shown to be short-term, although the levels of state anxiety and threat experiences in the high-risk group both remained at a slightly higher level than in the baseline. Threat experiences differed almost significantly (alpha = 0.017) between the Ɛ4+ and Ɛ4- groups (p = 0.034). Information on the apoE genotype impacted the experience of cardiovascular threat; this effect was most intense immediately after genetic feedback was received. However, fears of threat and anxiety may not be an obstacle for using gene information to motivate healthy, stable adults towards making lifestyle changes. Further studies should thus focus on how to utilize genetic screening in prevention of lifestyle-related diseases.
Functional Foods Forum, University of Turku, Kampusranta 9 C, 60320, Seinäjoki, Finland. hlhieta@utu.fi.
H-L
HL
Hietaranta-Luoma
Department of Marketing, University of Vaasa, Vaasa, Finland.
H T
HT
Luomala
Central Hospital of Southern Ostrobothnia, Seinäjoki, Finland.
H
H
Puolijoki
Functional Foods Forum, University of Turku, Kampusranta 9 C, 60320, Seinäjoki, Finland.
A
A
Hopia
D000328:Adult; D000544:Alzheimer Disease / Q000235:genetics* / Q000523:psychology*; D001007:Anxiety / Q000209:etiology; D053327:Apolipoprotein E4 / Q000235:genetics*; D005260:Female; D005387:Finland; D005817:Genetic Counseling / Q000523:psychology*; D020022:Genetic Predisposition to Disease / Q000523:psychology*; D005820:Genetic Testing; D005838:Genotype; D006801:Humans; D008019:Life Style; D008297:Male; D008875:Middle Aged
D053327:Apolipoprotein E4
Anxiety; ApoE; Genetic testing; Intervention; Stage of change; Threat